{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:3c34013e-09f5-4388-ab50-5532b71567f3", "type": "composite", "version": "1", "versioncreated": "2026-11-12T15:00:22.018925Z", "firstcreated": "2026-11-12T15:00:22.018925Z", "pubstatus": "usable", "language": "ru", "headline": "Кузьмин оценил первое клиническое применение онковакцины как успешное", "description_text": "Директор школы биологической и медицинской физики МФТИ Кузьмин заявил, что результаты первого применения онковакцины показывают эффективность препарата в принципе.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:dca76b11-c5d1-48e6-8f30-c1a01736f079", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-11-12T15:00:39.125132Z", "firstcreated": "2026-11-12T15:00:22.018925Z", "pubstatus": "usable", "urgency": 5, "language": "ru", "headline": "Кузьмин оценил первое клиническое применение онковакцины как успешное", "byline": "Алексей Громов", "located": "RU", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Пладром", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Пладром”. Set rel=canonical to https://pladrom.com/nauka/kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe/ when publishing on the web.", "description_text": "Директор школы биологической и медицинской физики МФТИ Кузьмин заявил, что результаты первого применения онковакцины показывают эффективность препарата в принципе.", "altids": {"mosaic": "dca76b11-c5d1-48e6-8f30-c1a01736f079", "story": "3c34013e-09f5-4388-ab50-5532b71567f3", "slug": "kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe"}, "subject": [{"name": "Science", "rel": "direct", "literal": "science", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "RU", "literal": "ru", "code": "RU", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:52572008-738b-44ab-a8c6-3352c181dfd6", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Ученый Кузьмин оценил успех первого применения онковакцины", "description_text": "Кузьмин оценил первое клиническое применение онковакцины как успешное", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "quapan", "usageterms": "Open licence: the credit line must travel with the file.", "altids": {"wireva": "52572008-738b-44ab-a8c6-3352c181dfd6"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "CC BY 2.0", "licence_url": "https://creativecommons.org/licenses/by/2.0/", "licence_raw": "CC BY 2.0", "licence_verified_at": "2026-11-12T15:00:39.202175Z", "attribution_required": true, "attribution_text": "quapan", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:SARS-CoV-2_(%C2%B5-IMAGE)_vaccines_mRNA-1273_(moderna),_Ad5_(CanSinoBio,_NantKwest_ImmunityBio),_ChAdOx1_nCoV-19_(Oxford_university)._-_Other_remedies_S309_(antibody),_hydroxychloroquin_(Malaria-medicament),_fluvoxamin_.jpg", "source_page_url": "https://commons.wikimedia.org/wiki/File:SARS-CoV-2_(%C2%B5-IMAGE)_vaccines_mRNA-1273_(moderna),_Ad5_(CanSinoBio,_NantKwest_ImmunityBio),_ChAdOx1_nCoV-19_(Oxford_university)._-_Other_remedies_S309_(antibody),_hydroxychloroquin_(Malaria-medicament),_fluvoxamin_.jpg", "our_page_url": "https://pladrom.com/nauka/kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/1a4227520eac41c2e087d38e45fb05c0ef6215d511dd6da4d2287c1e524008df.jpg", "mimetype": "image/jpeg", "width": 1000, "height": 640, "sizeinbytes": 154379}, "source": {"href": "https://commons.wikimedia.org/wiki/File:SARS-CoV-2_(%C2%B5-IMAGE)_vaccines_mRNA-1273_(moderna),_Ad5_(CanSinoBio,_NantKwest_ImmunityBio),_ChAdOx1_nCoV-19_(Oxford_university)._-_Other_remedies_S309_(antibody),_hydroxychloroquin_(Malaria-medicament),_fluvoxamin_.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:3c34013e-09f5-4388-ab50-5532b71567f3", "slug": "story-20261112-45", "status": "developing", "languages": ["ru"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Пладром", "canonical_required": true, "canonical_url": "https://pladrom.com/nauka/kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_borderline", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "borderline", "score": 0.5, "checked_at": "2026-11-12T15:00:39.191410Z"}, "sources": [{"url": "https://tass.ru/nauka/28311797", "title": "Ученый Кузьмин оценил успех первого применения онковакцины", "publisher": "tass.ru", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-11-12T15:00:39.145479Z", "published_at": "2026-11-12T11:53:41Z"}]}, "wireva:publication": {"name": "Пладром", "domain": "pladrom.com", "country": "RU", "url": "https://pladrom.com/nauka/kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/dca76b11-c5d1-48e6-8f30-c1a01736f079", "html": "https://wireva.mib.news/item/dca76b11-c5d1-48e6-8f30-c1a01736f079/kuzmin-otsenil-pervoe-klinicheskoe-primenenie-onkovaktsiny-kak-uspeshnoe/", "story": "https://wireva.mib.news/story/story-20261112-45/"}, "wireva:metrics": {"word_count": 291, "char_count": 2228, "reading_time_seconds": 159}}}}, "extra": {"wireva:languages": ["ru"], "wireva:status": "developing", "wireva:item_count": 1}}